Cargando…

In utero hematopoietic cell transplantation for hemoglobinopathies

In utero hematopoietic cell transplantation (IUHCTx) is a promising strategy to circumvent the challenges of postnatal hematopoietic stem cell (HSC) transplantation. The goal of IUHCTx is to introduce donor cells into a naïve host prior to immune maturation, thereby inducing donor–specific tolerance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Derderian, S. Christopher, Jeanty, Cerine, Walters, Mark C., Vichinsky, Elliott, MacKenzie, Tippi C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4290536/ https://www.ncbi.nlm.nih.gov/pubmed/25628564 http://dx.doi.org/10.3389/fphar.2014.00278

Ejemplares similares

Consensus statement from the first international conference for in utero stem cell transplantation and gene therapy
por: MacKenzie, Tippi C., et al.
Publicado: (2015)

In utero hematopoietic cell transplantation: induction of donor specific immune tolerance and postnatal transplants
por: Peranteau, William H.
Publicado: (2014)

Experimental and clinical progress of in utero hematopoietic cell transplantation therapy for congenital disorders
por: Shi, Chunyu, et al.
Publicado: (2022)

NK cell tolerance as the final endorsement of prenatal tolerance after in utero hematopoietic cellular transplantation
por: Alhajjat, Amir M., et al.
Publicado: (2015)

Immunological considerations in in utero hematopoetic stem cell transplantation (IUHCT)
por: Loewendorf, Andrea I., et al.
Publicado: (2015)

A Nonhuman Primate Transplantation Model to Evaluate Hematopoietic Stem Cell Gene Editing Strategies for β-Hemoglobinopathies
por: Humbert, Olivier, et al.
Publicado: (2017)

Hemophilia A: an ideal disease to correct in utero
por: Porada, Christopher D., et al.
Publicado: (2014)

Allogeneic hematopoietic stem cell transplantation in congenital hemoglobinopathies with myeloablative conditioning and rabbit anti-thymocyte globulin
por: Park, Bo-Kyoung, et al.
Publicado: (2018)

How to Facilitate Decision-Making for Hematopoietic Stem Cell Transplantation in Patients With Hemoglobinopathies. The Perspectives of Healthcare Professionals
por: Mekelenkamp, Hilda, et al.
Publicado: (2021)

Cell-based interventions in utero: time to reconsider
por: King, Nancy M. P., et al.
Publicado: (2014)

Stem cell transplantation for hemoglobinopathy Vila Real
por: Hasenkamp, Justin, et al.
Publicado: (2020)

Boosting Hematopoietic Engraftment after in Utero Transplantation through Vascular Niche Manipulation
por: Mokhtari, Saloomeh, et al.
Publicado: (2016)

Population Pharmacokinetic Model Development of Tacrolimus in Pediatric and Young Adult Patients Undergoing Hematopoietic Cell Transplantation
por: Brooks, Jordan T., et al.
Publicado: (2021)

In utero therapy for congenital disorders using amniotic fluid stem cells
por: Ramachandra, Durrgah L., et al.
Publicado: (2014)

Corrigendum: In utero therapy for congenital disorders using amniotic fluid stem cells
por: Ramachandra, Durrgah L., et al.
Publicado: (2015)

Ex Vivo Selection of Transduced Hematopoietic Stem Cells for Gene Therapy of β-Hemoglobinopathies
por: Bhukhai, Kanit, et al.
Publicado: (2018)

The impact of in utero transfusions on perinatal outcomes in patients with alpha thalassemia major: the UCSF registry
por: Schwab, Marisa E., et al.
Publicado: (2022)

In utero antidepressant exposure not associated with ADHD in the offspring: A case control sibling design
por: Hartwig, C. A. M., et al.
Publicado: (2022)

In utero Exposure to Atrazine Disrupts Rat Fetal Testis Development
por: Fang, Yinghui, et al.
Publicado: (2018)

Population Pharmacokinetics of Caspofungin and Dosing Optimization in Children With Allogeneic Hematopoietic Stem Cell Transplantation
por: Niu, Chang-He, et al.
Publicado: (2020)

Updates in Hemoglobinopathies
por: Al-Tonbary, Youssef, et al.
Publicado: (2013)

Sickle cell hemoglobinopathies in district Bhopal
por: Dangi, C. B. S., et al.
Publicado: (2010)

Population Pharmacokinetics and Initial Dosage Optimization of Tacrolimus in Pediatric Hematopoietic Stem Cell Transplant Patients
por: Liu, Xiao-Lin, et al.
Publicado: (2022)

Assessment of a Model-Informed Precision Dosing Platform Use in Routine Clinical Care for Personalized Busulfan Therapy in the Pediatric Hematopoietic Cell Transplantation (HCT) Population
por: Shukla, Praveen, et al.
Publicado: (2020)

In Utero Transplantation of Expanded Autologous Amniotic Fluid Stem Cells Results in Long‐Term Hematopoietic Engraftment
por: Loukogeorgakis, Stavros P., et al.
Publicado: (2019)

External Evaluation of Population Pharmacokinetic Models of Busulfan in Chinese Adult Hematopoietic Stem Cell Transplantation Recipients
por: Huang, Huiping, et al.
Publicado: (2022)

Maternal dendritic cells influence fetal allograft response following murine in-utero hematopoietic stem cell transplantation
por: Kandasamy, Karthikeyan, et al.
Publicado: (2023)

Impact of in-utero electronic cigarette exposure on neonatal neuroinflammation, oxidative stress and mitochondrial function
por: Archie, Sabrina Rahman, et al.
Publicado: (2023)

In-utero gastric perforation from combined duodenal and esophageal atresia without consistent polyhydramnios
por: Lyttle, Bailey D, et al.
Publicado: (2021)

Gene Therapy for Hemoglobinopathies
por: Cavazzana, Marina, et al.
Publicado: (2018)

Gene Therapy of the Hemoglobinopathies
por: Kunz, Joachim B., et al.
Publicado: (2020)

Hemoglobinopathy and COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Rare Combinational Hemoglobinopathies
por: Husan, Ammar, et al.
Publicado: (2022)

Effects of Posaconazole on Tacrolimus Population Pharmacokinetics and Initial Dose in Children With Crohn’s Disease Undergoing Hematopoietic Stem Cell Transplantation
por: Chen, Xiao, et al.
Publicado: (2022)

Population pharmacokinetics and initial dose optimization of tacrolimus in children with severe combined immunodeficiency undergoing hematopoietic stem cell transplantation
por: Chen, Xiao, et al.
Publicado: (2022)

Metabolic Reprogramming—A New Era How to Prevent and Treat Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Has Begun
por: Kumari, Reena, et al.
Publicado: (2020)

Ruxolitinib as an Effective and Steroid-Sparing First-Line Treatment in Newly Diagnosed BOS Patients After Hematopoietic Stem Cell Transplantation
por: Zhang, Xiaoyu, et al.
Publicado: (2022)

In Utero Hepatocellular Transplantation in Rats
por: Muñoz-Sáez, Emma, et al.
Publicado: (2013)

In Utero Haematopoietic Stem Cell Transplantation (IUHSCT)
por: Renda, Maria Concetta, et al.
Publicado: (2009)

New approaches for cholestasis in hemoglobinopathies
por: Dhiman, Pratibha, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7asqvfore22t7g0phk8nhdfril